Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By American Kabuki
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Goldman Sachs revenue slumps to lowest in more than four years

% of readers think this story is Fact. Add your two cents.


Musings On The Finite Statist Machine

A screen displays the ticker symbol and information for Goldman Sachs on the floor of the New York Stock Exchange (NYSE)  February 9, 2016. REUTERS/Brendan McDermid/File Photo

AK NOTE: 
I got this message thru Denice from Commander/Ambassador Mallieun, decided to wait until the news was out so I am not affecting markets with inside data, there may be other news to follow:

On Apr 17, 2016, at 8:06 AM, Denice wrote:

COMMANDER TERRAN. IN A PRIVATE COMMUNICATION TO YOU I SHARE A JUBILANT MESSAGE.  THE GRAND RELEASE OF DATA FLOWS SWIFTLY. HERE IS A RIDDLE FOR YOU. WATCH FOR THE “MAN WITH GOLD SACKS”. THIS WILL BE THE HERALD THAT PRECEDES ALL.  IN EXCITEMENT FOR OUR UPCOMING MOMENTS BOTH HERE AND THERE.  COMMANDER MALLIEUN.

Tue Apr 19, 2016 10:58am EDT
Goldman Sachs revenue slumps to lowest in more than four years
BY SUDARSHAN VARADHAN AND OLIVIA ORAN

Goldman Sachs Group Inc’s (GS.N) quarterly profit fell by more than half and revenue slumped to its lowest in more than four years as market volatility hit the Wall Street bank’s bond trading and investment banking businesses.

Goldman, wrapping up a dismal quarter for big U.S. banks, reported a 40 percent drop in net revenue, reflecting declines in all of its main businesses.

As with other banks, Goldman’s trading revenue was hit by sliding commodity and oil prices, worries about the Chinese economy and uncertainty about U.S. interest rates.

Highlighting the challenges facing the bank, Goldman’s return on average common equity – a measure of how well the bank uses shareholder money – was 6.4 percent in the quarter, down from 14.7 percent a year earlier. (bit.ly/22KtaAI)

Many investors think ROE should be at least 10 percent to cover the cost of capital.

Goldman, whose shares were up 2.2 percent at $162.42 in morning trading on Tuesday, said its revenue from trading bonds, currencies and commodities (FICC) fell about 47 percent. Equities trading revenue, normally a strength, slid 23 percent.

FICC accounted for 26.2 percent of total revenue in the quarter – a far cry from the 40 percent the business regularly contributed before the financial crisis.

“The market was braced for a weak quarter, but we think the breadth of weakness on the top line will be a disappointment as people try to grapple with the timing of the recovery,” Evercore ISI analyst Glenn Schorr wrote in a client note.

Goldman’s traditional rival, Morgan Stanley (MS.N), reported a 54 percent drop in adjusted revenue from fixed income and commodities trading and a similar drop in net profit. Its equities trading revenue fell 9.3 percent.

Goldman reported a 56.3 percent fall in net income applicable to common shareholders to $1.2 billion, or $2.68 per share, for the three months ended March 31. That compared with $2.75 billion, or $5.94 per share, a year earlier, when the bank recorded its best quarterly profit in five years.

Analysts on average had expected earnings of $2.45 per share, according to Thomson Reuters I/B/E/S.

Net revenue fell to $6.34 billion from $10.62 billion.

Still, Chief Financial Officer Harvey Schwartz express some optimism about market conditions in the current quarter.

“Although the market seems fragile … it feels like factors impacting the markets in the first quarter have abated,” Schwartz said on a call with analysts, adding that the bank would “do what it takes” to maximize returns for shareholders.

COMPENSATION COSTS DROP

Goldman’s investment banking revenue, which includes income from advising on deals and underwriting bond and share offerings, fell 23.2 percent to $1.46 billion in the quarter.

Goldman, like its rivals, has been cutting costs to make up for weak revenue.

Compensation costs fell 40.3 percent to $2.66 billion in the latest quarter. Operating costs fell 28.7 percent to $4.76 billion as employee compensation costs dropped about 40 percent.

Non-compensation costs fell 5.6 percent to $2.1 billion, the lowest in seven years, as a result of lower provisions for litigation and other regulatory matters.

Goldman Sachs, JPMorgan Chase & Co (JPM.N), Bank of America Corp (BAC.N) and Morgan Stanley together have cut nearly $4 billion in compensation costs since the first quarter of 2015, according to Reuters calculations.

Up to Monday’s close, Goldman’s shares had fallen about 12 percent since the start of the year, making the stock the worst performer in the Dow Jones industrial average .DJI.

(Reporting by Sudarshan Varadhan and Olivia Oran; Additional reporting by Richa Naidu; Editing by Ted Kerr)


Source: http://americankabuki.blogspot.com/2016/04/goldman-sachs-revenue-slumps-to-lowest.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.